Literature DB >> 10975310

C1q nephropathy presenting as rapidly progressive crescentic glomerulonephritis.

T Srivastava1, V Chadha, E M Taboada, U S Alon.   

Abstract

C1q nephropathy is an immune complex glomerulonephritis defined by the presence of mesangial immunoglobulins and complement deposits, most notably C1q, and the absence of clinical and laboratory evidence of systemic lupus erythematosus. Histology in C1q nephropathy is characterized by a slight to severe increase in mesangial cellularity and matrix, with or without segmental sclerosis. C1q nephropathy usually presents with nephrotic-range proteinuria in older children and young adults, and has a poor response to steroids. Patients may have decreased creatinine clearance at presentation, but progression to end-stage renal disease (ESRD) is slow. Severe crescentic glomerulonephritis has not been reported in C1q nephropathy. We describe a 3-year-old Hispanic girl who presented with renal insufficiency. Kidney biopsy showed C1q nephropathy with severe crescentic glomerulonephritis. The clinical and serological evaluation ruled out systemic lupus erythematosus or other immunological or infectious etiologies. In spite of immunosuppressive therapy, she progressed to ESRD within 14 weeks and is currently on chronic peritoneal dialysis. The atypical features of C1q nephropathy observed in our patient, which have not been described in earlier reports, are an early age of onset, severe crescentic glomerulonephritis, and rapid progression to ESRD. C1q nephropathy should be added to the differential diagnosis of glomerulonephritis in young children and in the patient with crescentic glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10975310     DOI: 10.1007/s004670050056

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  12 in total

Review 1.  C1q nephropathy in the pediatric population: pathology and pathogenesis.

Authors:  Scott E Wenderfer; Rita D Swinford; Michael C Braun
Journal:  Pediatr Nephrol       Date:  2010-02-24       Impact factor: 3.714

2.  C1q nephropathy in a child presenting with recurrent gross hematuria.

Authors:  Luke Taggart; Alexis Harris; Samir El-Dahr; Franca Iorember
Journal:  Pediatr Nephrol       Date:  2010-01       Impact factor: 3.714

3.  C1q nephropathy: features at presentation and outcome.

Authors:  Keith K Lau; Lillian W Gaber; Noel M Delos Santos; Robert J Wyatt
Journal:  Pediatr Nephrol       Date:  2005-04-13       Impact factor: 3.714

4.  C1q nephropathy in two young sisters.

Authors:  Jameela A Kari; Sawsan M Jalalah
Journal:  Pediatr Nephrol       Date:  2007-10-21       Impact factor: 3.714

5.  C1q nephropathy and minimal change nephrotic syndrome.

Authors:  Craig S Wong; Christopher A Fink; Jane Baechle; Alexis A Harris; Amy O Staples; John R Brandt
Journal:  Pediatr Nephrol       Date:  2008-12-11       Impact factor: 3.714

6.  A single-center study of C1q nephropathy in children.

Authors:  Isabel Roberti; Noosha Baqi; Shefali Vyas; Dae Un Kim
Journal:  Pediatr Nephrol       Date:  2008-08-08       Impact factor: 3.714

Review 7.  Current status and issues of C1q nephropathy.

Authors:  Akiko Mii; Akira Shimizu; Yukinari Masuda; Emiko Fujita; Kaoru Aki; Masamichi Ishizaki; Shigeru Sato; Adam Griesemer; Yuh Fukuda
Journal:  Clin Exp Nephrol       Date:  2009-04-17       Impact factor: 2.801

8.  Clinicopathologic correlation and outcome of C1q nephropathy.

Authors:  Satoshi Hisano; Yuko Fukuma; Yoshie Segawa; Kazuhiko Niimi; Yoshitsugu Kaku; Ken Hatae; Takao Saitoh; Morishige Takeshita; Hiroshi Iwasaki
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-23       Impact factor: 8.237

9.  Pathology, clinical presentations, and outcomes of C1q nephropathy.

Authors:  Alenka Vizjak; Dusan Ferluga; Mojca Rozic; Anastazija Hvala; Jelka Lindic; Tanja Kersnik Levart; Vesna Jurcić; J Charles Jennette
Journal:  J Am Soc Nephrol       Date:  2008-07-23       Impact factor: 10.121

10.  C1q nephropathy in a child with a chromosome 13 deletion.

Authors:  Isabel Roberti; Sachin Sachdev; Adam Aronsky; Dae Un Kim
Journal:  Pediatr Nephrol       Date:  2006-03-07       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.